Targeting mTOR Signaling Overcomes Acquired Resistance to Combined BRAF and MEK Inhibition in BRAF-Mutant Melanoma

By
Justin.choi
-
0
11
In vitro experiments showed that a subset of combination therapy melanoma cells was sensitive to mTORC1 inhibition.
[Oncogene]
Full Article